Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2012 1
2013 6
2014 2
2015 3
2016 2
2017 6
2018 8
2019 9
2020 18
2021 22
2022 20
2023 14
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Metaplastic breast cancer: A review.
Thomas HR, Hu B, Boyraz B, Johnson A, Bossuyt VI, Spring L, Jimenez RB. Thomas HR, et al. Among authors: jimenez rb. Crit Rev Oncol Hematol. 2023 Feb;182:103924. doi: 10.1016/j.critrevonc.2023.103924. Epub 2023 Jan 22. Crit Rev Oncol Hematol. 2023. PMID: 36696934 Review.
ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.
Kaidar-Person O, Vrou Offersen B, Hol S, Arenas M, Aristei C, Bourgier C, Cardoso MJ, Chua B, Coles CE, Engberg Damsgaard T, Gabrys D, Jagsi R, Jimenez R, Kirby AM, Kirkove C, Kirova Y, Kouloulias V, Marinko T, Meattini I, Mjaaland I, Nader Marta G, Witt Nystrom P, Senkus E, Skyttä T, Tvedskov TF, Verhoeven K, Poortmans P. Kaidar-Person O, et al. Among authors: jimenez r. Radiother Oncol. 2019 Aug;137:159-166. doi: 10.1016/j.radonc.2019.04.010. Epub 2019 May 17. Radiother Oncol. 2019. PMID: 31108277
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses.
Mandula JK, Chang S, Mohamed E, Jimenez R, Sierra-Mondragon RA, Chang DC, Obermayer AN, Moran-Segura CM, Das S, Vazquez-Martinez JA, Prieto K, Chen A, Smalley KSM, Czerniecki B, Forsyth P, Koya RC, Ruffell B, Cubillos-Ruiz JR, Munn DH, Shaw TI, Conejo-Garcia JR, Rodriguez PC. Mandula JK, et al. Among authors: jimenez r. Cancer Cell. 2022 Oct 10;40(10):1145-1160.e9. doi: 10.1016/j.ccell.2022.08.016. Epub 2022 Sep 22. Cancer Cell. 2022. PMID: 36150390 Free PMC article.
Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.
Mutter RW, Choi JI, Jimenez RB, Kirova YM, Fagundes M, Haffty BG, Amos RA, Bradley JA, Chen PY, Ding X, Carr AM, Taylor LM, Pankuch M, Vega RBM, Ho AY, Nyström PW, McGee LA, Urbanic JJ, Cahlon O, Maduro JH, MacDonald SM. Mutter RW, et al. Among authors: jimenez rb. Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):337-359. doi: 10.1016/j.ijrobp.2021.05.110. Epub 2021 May 25. Int J Radiat Oncol Biol Phys. 2021. PMID: 34048815 Free PMC article. Review.
Understanding Propensity Score Analyses.
Lalani N, Jimenez RB, Yeap B. Lalani N, et al. Among authors: jimenez rb. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):404-407. doi: 10.1016/j.ijrobp.2020.02.638. Int J Radiat Oncol Biol Phys. 2020. PMID: 32531385 No abstract available.
Particle Therapy for Breast Cancer.
Kowalchuk RO, Corbin KS, Jimenez RB. Kowalchuk RO, et al. Among authors: jimenez rb. Cancers (Basel). 2022 Feb 20;14(4):1066. doi: 10.3390/cancers14041066. Cancers (Basel). 2022. PMID: 35205814 Free PMC article. Review.
Hadrontherapy techniques for breast cancer.
Loap P, De Marzi L, Almeida CE, Barcellini A, Bradley J, de Santis MC, Dendale R, Jimenez R, Orlandi E, Kirova Y. Loap P, et al. Among authors: jimenez r. Crit Rev Oncol Hematol. 2022 Jan;169:103574. doi: 10.1016/j.critrevonc.2021.103574. Epub 2021 Dec 24. Crit Rev Oncol Hematol. 2022. PMID: 34958916 Review.
Therapeutic Lowering of C-Reactive Protein.
Jimenez RV, Szalai AJ. Jimenez RV, et al. Front Immunol. 2021 Jan 29;11:619564. doi: 10.3389/fimmu.2020.619564. eCollection 2020. Front Immunol. 2021. PMID: 33633738 Free PMC article. Review.
DCIS: Risk Assessment in the Molecular Era.
Knowlton CA, Jimenez RB, Moran MS. Knowlton CA, et al. Among authors: jimenez rb. Semin Radiat Oncol. 2022 Jul;32(3):189-197. doi: 10.1016/j.semradonc.2022.01.005. Semin Radiat Oncol. 2022. PMID: 35688517 Review.
Optimizing Informed Consent in Cancer Clinical Trials.
Perni S, Jimenez R, Jagsi R. Perni S, et al. Among authors: jimenez r. Semin Radiat Oncol. 2023 Oct;33(4):349-357. doi: 10.1016/j.semradonc.2023.06.001. Semin Radiat Oncol. 2023. PMID: 37684064 Review.
98 results